Despite Heightened Concerns Over Influenza, the Most Commercially Important Viral Infections for Drug Developers Remain HIV, Hepatitis C, and Hepatitis B
WALTHAM, Mass. -- Decision Resources, Inc., a leading research and advisory firm focusing on pharmaceutical and healthcare issues, finds that HIV, hepatitis C, and hepatitis B are the most important viral infections for drug developers. According to a new Spectrum report titled, Emerging Antiviral Drug Targets, large patient populations, high medical need, and the potential for chronic treatment make these drug markets lucrative for the biopharmaceutical industry.
Among these three infectious diseases, HIV has yielded the highest number of viable drug targets and candidates, partly because of the high level of investment in HIV research and the availability of predictive in vitro models for drug testing.
"Hepatitis C drug development has been hampered by the lack of reliable cell culture systems and animal infection models, but several promising targets, including protease and polymerase, have yielded drug candidates that could potentially revolutionize the treatment of hepatitis C," says John Lebbos, therapeutic area director of infectious diseases at Decision Resources, Inc. "In contrast to HIV and hepatitis C, which have a more diverse array of approaches in advanced stages of development, hepatitis B virus drug development is relatively concentrated within nucleoside analogues."
Source: Decision Resources, Inc.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
